Evenity (romosozumab-aqqg) - Astellas, Amgen, UCB
Effect of Romosozumab on Bone Metabolism, Lipid Profile, and Laboratory Parameters in Real-World Clinical Practice. (ACR Convergence 2026) - Sep 8, 2026 - Abstract #2555; Pres time: Nov 10, 2026; 10:30 AM - 12:30 PM; Location: WB1&2; In Person; No abstract available 
Clinical • Real-world • Real-world evidence • Orthopedics • Osteoporosis • Rheumatology
https://eppro02.ativ.me/web/page.php?nav=false&page=Session&project=ACR26&id=3570793
 
Mitndbaim Aelohim Parra Moreno, MD
 
Sep 8, 2026
 
Prev Next